Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland
The association of Swiss Memory Clinics (SMC) provides intersocietal recommendations for the use of anti-amyloid monoclonal antibodies (mAbs) in Switzerland. The recommendations are the result of extensive interdisciplinary discussions in a group of Swiss dementia experts from August 2023 until December 2024. They reflect the opinion of all societies involved in the diagnosis and treatment of dementia patients in Switzerland. Special emphasis is given to aspects that are specific to the Swiss landscape, including recommendations for infrastructural and personnel standards for institutions aiming to administer anti-amyloid mAbs in Switzerland.
Authors
- Ansgar Felbecker
- Andreas U. Monsch (ORCID: https://orcid.org/0000-0003-1692-1560)
- Karl‐Olof Lövblad (ORCID: https://orcid.org/0000-0003-2768-9779)
- Markus Bürge (ORCID: https://orcid.org/0000-0003-0225-3979)
- Julius Popp (ORCID: https://orcid.org/0000-0002-0068-0312)
- Tatjana Meyer-Heim
- Rafael Meyer (ORCID: https://orcid.org/0000-0002-7668-9794)
- Hans H. Jung
- Anton Gietl (ORCID: https://orcid.org/0000-0001-8604-962X)
- Gilles Allali (ORCID: https://orcid.org/0000-0002-4455-6719)
- Marc Sollberger (ORCID: https://orcid.org/0000-0001-8863-3731)
- Olivier Rouaud (ORCID: https://orcid.org/0000-0001-9767-8421)
- Stefanie Becker (ORCID: https://orcid.org/0000-0001-8503-6368)
- Giovanni B. Frisoni (ORCID: https://orcid.org/0000-0001-7075-7082)
- Nadège Barro-Belaygues
- Dan Georgescu
- Kathrin Lindheimer
- Aurelien Lathuilliere
Institutions
- University of Zurich (CH)
- University Hospital of Bern (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- University Hospital of Basel (CH)
- Klinik Hirslanden (CH)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
- NeuroDevelopment Center (US)
- Swiss Society of Radiology (CH)
- Felix Platter-Hospital (CH)
- Swiss Society of Hypertension (CH)
- Swiss Institute for Management and Hospitality (CH)
- Alzheimer Schweiz (CH)
- Société Suisse de Dermatologie et Vénéréologie (CH)
- Arab Foundations Forum (JO)
- Lindenhofspital (CH)
- The Memory Clinic (US)
- Spitalzentrum Centre hospitalier Biel- Bienne (CH)
- Praxis (EE)
- University of Lausanne (CH)
Publication Details
- Journal
- Neurodegenerative Diseases
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1159/000545799
- Citations
- 3
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- National Science Foundation
- Eli Lilly and Company
- Biogen
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Eisai
- Novo Nordisk
- Hôpitaux Universitaires de Genève
- Université de Genève
- H. Lundbeck A/S
- Fondation Segré
- Horizon 2020 Framework Programme
- Novo Nordisk Pharma